Published in Lancet on March 24, 2001
What went wrong? The flawed concept of cerebrospinal venous insufficiency. J Cereb Blood Flow Metab (2013) 1.19
Internal jugular vein valve incompetence and intracranial venous anatomy in transient global amnesia. J Neurol Neurosurg Psychiatry (2005) 1.04
Ischemic evidence of transient global amnesia: location of the lesion in the hippocampus. J Clin Neurol (2008) 0.90
No evidence of jugular venous valve insufficiency in patients with migraine--a controlled study. J Headache Pain (2013) 0.80
Time of flight MR angiography assessment casts doubt on the association between transient global amnesia and intracranial jugular venous reflux. Eur Radiol (2014) 0.79
Venous endothelial injury in central nervous system diseases. BMC Med (2013) 0.77
Longitudinal Cerebral Perfusion Change in Transient Global Amnesia Related to Left Posterior Medial Network Disruption. PLoS One (2015) 0.75
Transient global amnesia during transoesophageal echocardiogram. Neurol Sci (2008) 0.75
Aetiology of transient global amnesia. Lancet (1998) 3.09
Disturbance of venous flow patterns in patients with transient global amnesia. Lancet (2000) 1.83
Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology (1999) 2.44
Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38
MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology (2004) 2.07
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
Transient global amnesia as a presenting aura. Headache (2014) 1.95
Vertebrobasilar ischemia after neck motion. Stroke (1991) 1.91
Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum Mutat (2009) 1.77
Object and action naming in Alzheimer's disease and frontotemporal dementia [see comment]. Neurology (1998) 1.71
Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus (1999) 1.70
Unilateral neglect restricted to visual imagery. Nature (1993) 1.66
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging (2007) 1.65
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
A complicated case of intracranial hypotension: diagnostic and management strategies. Neurol Sci (2006) 1.44
The disappearance of the "cold patch" in recovered migraine patients: thermographic findings. Headache (1991) 1.44
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry (2005) 1.40
Are there objective criteria to follow up migrainous patients? A prospective study with thermography and evoked potentials. Headache (1988) 1.38
Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging (2005) 1.37
Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37
Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.26
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. J Neurol Sci (2001) 1.20
Transient global amnesia: a clinical and sonographic study. Eur Neurol (2003) 1.17
Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia (1994) 1.13
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. Rejuvenation Res (2010) 1.12
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology (2004) 1.12
History of migraine and the risk of spontaneous cervical artery dissection. Cephalalgia (2005) 1.08
Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 1.06
Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. AJNR Am J Neuroradiol (2009) 1.05
Myasthenic crisis during intravenous iodinated contrast medium injection. Ital J Neurol Sci (1986) 1.03
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. Neuropsychology (2006) 1.01
Brain magnetic resonance imaging structural changes in a pedigree of asymptomatic progranulin mutation carriers. Rejuvenation Res (2008) 0.99
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (2001) 0.98
Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol (2003) 0.98
Spatial compatibility and anatomical factors in simple and choice reaction time. Neuropsychologia (1977) 0.97
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study. J Neurol Neurosurg Psychiatry (2006) 0.96
Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome. Curr Med Chem (2010) 0.94
Regional grey matter loss and brain disconnection across Alzheimer disease evolution. Curr Med Chem (2011) 0.93
The contribution of TMS to frontotemporal dementia variants. Acta Neurol Scand (2008) 0.91
Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression. Neurobiol Aging (2008) 0.91
Visual and spatial perception in the early phase of Alzheimer's disease. Neuropsychology (1998) 0.90
Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. Neurol Sci (2011) 0.90
Revisiting brain reserve hypothesis in frontotemporal dementia: evidence from a brain perfusion study. Dement Geriatr Cogn Disord (2009) 0.90
No association of the -105 promoter polymorphism of the selenoprotein S encoding gene SEPS1 with cerebrovascular disease. Eur J Neurol (2007) 0.90
Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia. Eur J Neurol (2012) 0.89
Procedural memory stimulation in Alzheimer's disease: impact of a training programme. Acta Neurol Scand (1997) 0.89
The Mini-Mental State Examination in Alzheimer's disease and multi-infarct dementia. Int Psychogeriatr (1996) 0.89
Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex (1991) 0.89
Segmental neurofibromatosis. Case report and review of the literature. Neurofibromatosis (1988) 0.89
The Italian version of the pain assessment in advanced dementia (PAINAD) scale. Arch Gerontol Geriatr (2006) 0.88
Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging (2005) 0.88
Motor recovery after early brain damage. A case of brain plasticity. Stroke (1994) 0.88
Interaction of homocysteine and conventional predisposing factors on risk of ischaemic stroke in young people: consistency in phenotype-disease analysis and genotype-disease analysis. J Neurol Neurosurg Psychiatry (2006) 0.88
Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study. J Neurol (2005) 0.88
Validity of direct assessment of functional status as a tool for measuring Alzheimer's disease severity. Age Ageing (1998) 0.87
Action and object naming in Parkinson's disease without dementia. Eur J Neurol (2007) 0.87
Holmes' tremor following midbrain Toxoplasma abscess: clinical features and treatment of a case. Parkinsonism Relat Disord (2002) 0.87
Transcranial Doppler in the diagnosis of cardiac patent foramen ovale. Neurol Sci (2001) 0.87
Volume reduction in cerebral blood flow in patients with Alzheimer's disease: a sonographic study. Dement Geriatr Cogn Disord (2003) 0.86
Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology (2008) 0.86
Dementia, delusions and seizures: storage disease or genetic AD? Eur J Neurol (2007) 0.86
The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Eur J Neurol (2009) 0.86
Transforming growth factor β signaling perturbation in the Loeys-Dietz syndrome. Curr Med Chem (2012) 0.85
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. Neurol Sci (2007) 0.85
Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol (2000) 0.85
Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem (2009) 0.85
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease. Curr Med Chem (2013) 0.85
Transient global amnesia and venous flow patterns. Lancet (2001) 0.85
Temporal lobe asymmetry in patients with Alzheimer's disease with delusions. J Neurol Neurosurg Psychiatry (2000) 0.85
Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. Arch Neurol (2001) 0.85
Screening for cognitive impairment, Alzheimer's disease and other dementias: opinions of European caregivers, payors, physicians and the general public. J Nutr Health Aging (2010) 0.84
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. Arch Gerontol Geriatr (2007) 0.84
Disorders of visual and spatial perception in the early stage of Alzheimer's disease. Ann N Y Acad Sci (1996) 0.84
Neurotoxicity of cobalt. Hum Exp Toxicol (2011) 0.84
Behavioral disorders in Alzheimer disease: a transcultural perspective. Arch Neurol (1998) 0.84
Behavioral and psychological symptoms in dementia with Lewy-bodies (DLB): frequency and relationship with disease severity and motor impairment. Arch Gerontol Geriatr (2007) 0.84